<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">After analysis of hospital records at four German sites (University Cologne, University Essen, University Munich, Asklepios Hospital Hamburg), 90 patients were identified fulfilling the inclusion criteria. Thirty-nine were treated during the pre-plerixafor era and 51 were treated during the plerixafor era. Baseline characteristics between the two patient groups were comparable (Table 
 <xref rid="Tab1" ref-type="table">1</xref>). The initial CD34+ count was significantly higher in the pre-plerixafor than in the plerixafor era (
 <italic>p</italic> &lt; 0.001).
</p>
